Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Blood donors' positivity for transfusion-transmissible infections: the Serbian Military Medical Academy experience.

Vučetić D, Kecman G, Ilić V, Balint B.

Blood Transfus. 2015 Oct;13(4):569-75. doi: 10.2450/2015.0314-14. Epub 2015 May 22.

2.

Occult hepatitis B virus infection and blood transfusion.

Seo DH, Whang DH, Song EY, Han KS.

World J Hepatol. 2015 Mar 27;7(3):600-6. doi: 10.4254/wjh.v7.i3.600. Review.

3.

Guidance on the use of increased infectious risk donors for organ transplantation.

CSTCNTRP increased risk donor working group.

Transplantation. 2014 Aug 27;98(4):365-9. doi: 10.1097/TP.0000000000000251. No abstract available.

4.

Evaluation of an isolation program of hepatitis C virus infected hemodialysis patients in some hemodialysis centers in egypt.

Soliman AR, Momtaz Abd Elaziz M, El Lawindi MI.

ISRN Nephrol. 2012 Oct 31;2013:395467. doi: 10.5402/2013/395467. eCollection 2013.

5.

Accuracy of physician reporting in routine public health surveillance for hepatitis C virus infection.

Jochem K, Leclerc P, Maurais E, Tremblay C, Cox J.

Public Health Rep. 2014 Jan-Feb;129(1):64-72.

6.

Undisclosed human immunodeficiency virus risk factors identified through a computer-based questionnaire program among blood donors in Brazil.

Blatyta PF, Custer B, Gonçalez TT, Birch R, Lopes ME, Lopes Ferreira MI, Carneiro Proietti AB, Sabino EC, Page K, de Almeida-Neto C; NHLBI Retrovirus Epidemiology Donor Study-II International Component.

Transfusion. 2013 Nov;53(11):2734-43. doi: 10.1111/trf.12166. Epub 2013 Mar 22.

7.

Prevalence, incidence, and residual risks for transfusion-transmitted human immunodeficiency virus Types 1 and 2 infection among Chinese blood donors.

Wang J, Liu J, Yao F, Wen G, Li J, Huang Y, Lü Y, Wen X, Wright D, Yu Q, Guo N, Ness P, Shan H; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) and International Component.

Transfusion. 2013 Jun;53(6):1240-9. doi: 10.1111/j.1537-2995.2012.03940.x. Epub 2012 Nov 1.

8.
9.

Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.

Carson JL, Carless PA, Hebert PC.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD002042. doi: 10.1002/14651858.CD002042.pub3. Review.

10.

Reducing the risk of hepatitis B virus transfusion-transmitted infection.

Niederhauser C.

J Blood Med. 2011;2:91-102. doi: 10.2147/JBM.S12899. Epub 2011 Jul 18.

11.

Pre- and post-transfusion testing for hepatitis B virus surface antigen and antibody in blood recipients: a single-institution experience in an area of high endemicity.

Kim H, Hur M, Moon HW, Park CM, Cho JH, Park KS, Lee K, Chang S.

Ann Lab Med. 2012 Jan;32(1):73-8. doi: 10.3343/alm.2012.32.1.73. Epub 2011 Dec 20.

12.

Do expert assessments converge? An exploratory case study of evaluating and managing a blood supply risk.

Eyles J, Heddle N, Webert K, Arnold E, McCurdy B.

BMC Public Health. 2011 Aug 24;11:666. doi: 10.1186/1471-2458-11-666.

13.

Detection of prion protein in urine-derived injectable fertility products by a targeted proteomic approach.

Van Dorsselaer A, Carapito C, Delalande F, Schaeffer-Reiss C, Thierse D, Diemer H, McNair DS, Krewski D, Cashman NR.

PLoS One. 2011 Mar 23;6(3):e17815. doi: 10.1371/journal.pone.0017815.

14.

Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

Ricerca BM, Di Girolamo A, Rund D.

Mediterr J Hematol Infect Dis. 2009 Dec 28;1(1):e2009028. doi: 10.4084/MJHID.2009.028.

15.

Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.

Kucirka LM, Sarathy H, Govindan P, Wolf JH, Ellison TA, Hart LJ, Montgomery RA, Ros RL, Segev DL.

Am J Transplant. 2011 Jun;11(6):1188-200. doi: 10.1111/j.1600-6143.2011.03460.x. Epub 2011 Mar 14. Review.

16.

Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis.

Kucirka LM, Sarathy H, Govindan P, Wolf JH, Ellison TA, Hart LJ, Montgomery RA, Ros RL, Segev DL.

Am J Transplant. 2011 Jun;11(6):1176-87. doi: 10.1111/j.1600-6143.2010.03329.x. Epub 2011 Mar 2. Review.

17.

Clinical review: Fresh frozen plasma in massive bleedings - more questions than answers.

Nascimento B, Callum J, Rubenfeld G, Neto JB, Lin Y, Rizoli S.

Crit Care. 2010;14(1):202. doi: 10.1186/cc8205. Epub 2010 Jan 28. Review.

18.

Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components.

Liumbruno GM, Catalano L, Piccinini V, Pupella S, Grazzini G.

Blood Transfus. 2009 Apr;7(2):86-93. doi: 10.2450/2008.0026-08. Review. No abstract available.

19.

Vertical transmission of the hepatitis C virus: Current knowledge and issues.

[No authors listed]

Paediatr Child Health. 2008 Jul;13(6):529-41. English, French. No abstract available.

20.

What every physician should know about transfusion reactions.

Bakdash S, Yazer MH.

CMAJ. 2007 Jul 17;177(2):141-7. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk